The primary applications of these types of microarrays have dealt with automated high-throughput identification of mutations in critical genes such as TP53, a valuable predictor for bladder cancer outcome (Lu et al, 2002), and in the genotyping of single-nucleotide polymorphisms (SNPs) (Primdahl et al, 2002). Here, TP53 is linked to urinary bladder carcinoma.